The 81st Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 1-7D Multiple Myeloma: Novel Agents

Fri. Oct 11, 2019 4:30 PM - 5:30 PM No.7 (Tokyo International Forum, 5F Hall D5)

Chair: Chiaki Nakaseko (Department of Hematology, International University of Health and Welfare School of Medicine)

[OS1-7D-4] OPTIMISMM: pomalidomide + bortezomib + low-dose dexamethasone (PVd) in Japanese patients

Kenshi Suzuki1, Kosei Matsue2, Kazutaka Sunami3, Naoki Takezako4, Atsushi Shinagawa5, Sanae Sakurai6, Hiromi Tamakoshi6, Tsvetan Biyukov7, Teresa Peluso7, Paul G. Richardson8 (1.Japanese Red Cross Medical Center, 2.Kameda Medical Center, 3.National Hospital Organization Okayama Medical Center, 4.National Hospital Organization Disaster Medical Center, 5.Hitachi General Hospital, Ibaraki, Japan, 6.Celgene K.K., Japan, 7.Celgene International Sarl, 8.Dana-Farber Cancer Institute)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.

Password